vs
AVIAT NETWORKS, INC.（AVNW）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
AVIAT NETWORKS, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$111.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -5.7%），AVIAT NETWORKS, INC.自由现金流更多（$22.5M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 0.3%）
Aviat Networks是全球领先的微波传输与回传解决方案供应商，为公共及私营通信运营商提供通信基础设施支撑，同时也面向企业客户提供相关产品与服务，助力客户构建稳定高效的通信网络。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
AVNW vs PBYI — 直观对比
营收规模更大
AVNW
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出33.4%
-5.7%
自由现金流更多
AVNW
多$8.1M
$14.4M
两年增速更快
PBYI
近两年复合增速
0.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $111.5M | $75.5M |
| 净利润 | $5.7M | — |
| 毛利率 | 32.4% | 69.3% |
| 营业利润率 | 6.5% | 22.7% |
| 净利率 | 5.1% | — |
| 营收同比 | -5.7% | 27.7% |
| 净利润同比 | 27.2% | — |
| 每股收益（稀释后） | $0.44 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVNWPBYI
| Q4 25 | $111.5M | $75.5M | ||
| Q3 25 | $107.3M | $54.5M | ||
| Q2 25 | $115.3M | $52.4M | ||
| Q1 25 | $112.6M | $46.0M | ||
| Q4 24 | $118.2M | $59.1M | ||
| Q3 24 | $88.4M | $80.5M | ||
| Q2 24 | $116.7M | $47.1M | ||
| Q1 24 | $110.8M | $43.8M |
净利润AVNWPBYI
| Q4 25 | $5.7M | — | ||
| Q3 25 | $162.0K | $8.8M | ||
| Q2 25 | $5.2M | $5.9M | ||
| Q1 25 | $3.5M | $3.0M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $-11.9M | $20.3M | ||
| Q2 24 | $1.5M | $-4.5M | ||
| Q1 24 | $3.9M | $-4.8M |
毛利率AVNWPBYI
| Q4 25 | 32.4% | 69.3% | ||
| Q3 25 | 33.2% | 77.7% | ||
| Q2 25 | 34.2% | 76.5% | ||
| Q1 25 | 34.9% | 77.1% | ||
| Q4 24 | 34.6% | 76.4% | ||
| Q3 24 | 22.4% | 63.9% | ||
| Q2 24 | 35.3% | 77.4% | ||
| Q1 24 | 32.5% | 75.5% |
营业利润率AVNWPBYI
| Q4 25 | 6.5% | 22.7% | ||
| Q3 25 | 4.8% | 17.6% | ||
| Q2 25 | 7.7% | 12.7% | ||
| Q1 25 | 8.3% | 8.7% | ||
| Q4 24 | 6.7% | 22.6% | ||
| Q3 24 | -17.6% | 27.4% | ||
| Q2 24 | 4.7% | -4.6% | ||
| Q1 24 | 5.1% | -5.3% |
净利率AVNWPBYI
| Q4 25 | 5.1% | — | ||
| Q3 25 | 0.2% | 16.2% | ||
| Q2 25 | 4.5% | 11.2% | ||
| Q1 25 | 3.1% | 6.5% | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | -13.4% | 25.2% | ||
| Q2 24 | 1.3% | -9.6% | ||
| Q1 24 | 3.5% | -11.0% |
每股收益（稀释后）AVNWPBYI
| Q4 25 | $0.44 | $0.26 | ||
| Q3 25 | $0.01 | $0.17 | ||
| Q2 25 | $0.42 | $0.12 | ||
| Q1 25 | $0.27 | $0.06 | ||
| Q4 24 | $0.35 | $0.40 | ||
| Q3 24 | $-0.94 | $0.41 | ||
| Q2 24 | $0.11 | $-0.09 | ||
| Q1 24 | $0.30 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $86.5M | $97.5M |
| 总债务越低越好 | $105.4M | $22.7M |
| 股东权益账面价值 | $271.6M | $130.3M |
| 总资产 | $659.4M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.39× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资AVNWPBYI
| Q4 25 | $86.5M | $97.5M | ||
| Q3 25 | $64.8M | $94.4M | ||
| Q2 25 | $59.7M | $96.0M | ||
| Q1 25 | $49.4M | $93.2M | ||
| Q4 24 | $52.6M | $101.0M | ||
| Q3 24 | $51.0M | $96.7M | ||
| Q2 24 | $64.6M | $96.8M | ||
| Q1 24 | $59.2M | $107.2M |
总债务AVNWPBYI
| Q4 25 | $105.4M | $22.7M | ||
| Q3 25 | $106.5M | $34.0M | ||
| Q2 25 | $87.6M | $45.3M | ||
| Q1 25 | $73.9M | $56.7M | ||
| Q4 24 | $74.9M | $68.0M | ||
| Q3 24 | $83.4M | $79.3M | ||
| Q2 24 | $48.4M | $90.7M | ||
| Q1 24 | $48.9M | $102.0M |
股东权益AVNWPBYI
| Q4 25 | $271.6M | $130.3M | ||
| Q3 25 | $263.6M | $115.3M | ||
| Q2 25 | $263.2M | $104.7M | ||
| Q1 25 | $256.1M | $97.1M | ||
| Q4 24 | $249.6M | $92.1M | ||
| Q3 24 | $247.1M | $71.1M | ||
| Q2 24 | $255.9M | $48.5M | ||
| Q1 24 | $256.0M | $51.0M |
总资产AVNWPBYI
| Q4 25 | $659.4M | $216.3M | ||
| Q3 25 | $643.3M | $202.9M | ||
| Q2 25 | $633.3M | $194.9M | ||
| Q1 25 | $628.3M | $196.2M | ||
| Q4 24 | $594.1M | $213.3M | ||
| Q3 24 | $590.9M | $220.7M | ||
| Q2 24 | $535.2M | $205.0M | ||
| Q1 24 | $490.3M | $214.1M |
负债/权益比AVNWPBYI
| Q4 25 | 0.39× | 0.17× | ||
| Q3 25 | 0.40× | 0.30× | ||
| Q2 25 | 0.33× | 0.43× | ||
| Q1 25 | 0.29× | 0.58× | ||
| Q4 24 | 0.30× | 0.74× | ||
| Q3 24 | 0.34× | 1.12× | ||
| Q2 24 | 0.19× | 1.87× | ||
| Q1 24 | 0.19× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $23.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $22.5M | $14.4M |
| 自由现金流率自由现金流/营收 | 20.2% | 19.1% |
| 资本支出强度资本支出/营收 | 1.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.18× | — |
| 过去12个月自由现金流最近4个季度 | $16.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流AVNWPBYI
| Q4 25 | $23.9M | $14.4M | ||
| Q3 25 | $-11.7M | $9.7M | ||
| Q2 25 | $10.5M | $14.1M | ||
| Q1 25 | $1.6M | $3.6M | ||
| Q4 24 | $20.8M | $15.6M | ||
| Q3 24 | $-27.2M | $11.0M | ||
| Q2 24 | $8.3M | $1.0M | ||
| Q1 24 | $15.3M | $11.2M |
自由现金流AVNWPBYI
| Q4 25 | $22.5M | $14.4M | ||
| Q3 25 | $-13.5M | $9.7M | ||
| Q2 25 | $8.2M | $14.1M | ||
| Q1 25 | $-1.2M | $3.6M | ||
| Q4 24 | $18.3M | $15.6M | ||
| Q3 24 | $-32.6M | $11.0M | ||
| Q2 24 | $7.5M | $1.0M | ||
| Q1 24 | $14.8M | — |
自由现金流率AVNWPBYI
| Q4 25 | 20.2% | 19.1% | ||
| Q3 25 | -12.6% | 17.7% | ||
| Q2 25 | 7.1% | 26.8% | ||
| Q1 25 | -1.0% | 7.7% | ||
| Q4 24 | 15.5% | 26.4% | ||
| Q3 24 | -36.8% | 13.7% | ||
| Q2 24 | 6.4% | 2.1% | ||
| Q1 24 | 13.4% | — |
资本支出强度AVNWPBYI
| Q4 25 | 1.3% | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 2.5% | 0.1% | ||
| Q4 24 | 2.1% | 0.0% | ||
| Q3 24 | 6.1% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.4% | 0.0% |
现金转化率AVNWPBYI
| Q4 25 | 4.18× | — | ||
| Q3 25 | -72.48× | 1.10× | ||
| Q2 25 | 2.02× | 2.41× | ||
| Q1 25 | 0.46× | 1.21× | ||
| Q4 24 | 4.62× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 5.37× | — | ||
| Q1 24 | 3.96× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVNW
| Products | $81.2M | 73% |
| Services | $30.3M | 27% |
PBYI
暂无分部数据
